Response-adapted intensification with cyclophosphamide,...

  • Main
  • 2019 / 10
  • Response-adapted intensification with cyclophosphamide,...

Response-adapted intensification with cyclophosphamide, bortezomib, and dexamethasone versus no intensification in patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

Jackson, Graham H, Davies, Faith E, Pawlyn, Charlotte, Cairns, David A, Striha, Alina, Collett, Corinne, Waterhouse, Anna, Jones, John R, Kishore, Bhuvan, Garg, Mamta, Williams, Cathy D, Karunanithi,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
The Lancet Haematology
DOI:
10.1016/S2352-3026(19)30167-X
Date:
October, 2019
File:
PDF, 669 KB
english, 2019
Conversion to is in progress
Conversion to is failed